Report cover image

Global Drugs for Schistosomiasis Competitive Landscape Professional Research Report 2025

Publisher DIResearch
Published Jan 23, 2025
Length 170 Pages
SKU # DIR19532268

Description

Global Drugs for Schistosomiasis Competitive Landscape Professional Research Report 2025



Research Summary

Drugs for schistosomiasis are medications used to treat infections caused by parasitic worms of the Schistosoma genus. Praziquantel is the primary drug employed for treating all forms of schistosomiasis, a neglected tropical disease prevalent in areas with inadequate sanitation and freshwater exposure. Praziquantel targets the adult parasites, causing muscle paralysis and eventual death, allowing the body to eliminate them. The drug＇s effectiveness has made it a cornerstone of schistosomiasis control and elimination efforts. Given the disease＇s impact on millions of people, especially in Africa, praziquantel distribution and treatment campaigns are crucial components of public health strategies to combat schistosomiasis and reduce its health and socioeconomic burden.

According to DIResearch's in-depth investigation and research, the global Drugs for Schistosomiasis market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.

The major global  manufacturers of Drugs for Schistosomiasis include Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma, Taj Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Drugs for Schistosomiasis. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Drugs for Schistosomiasis market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Drugs for Schistosomiasis market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drugs for Schistosomiasis industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Drugs for Schistosomiasis Include:

Shin Poong

Merck

Bayer

EIPICO

Chandra Bhagat Pharma

Taj Pharmaceuticals

Drugs for Schistosomiasis Product Segment Include:

Praziquantel

Oxamniquine

Others

Drugs for Schistosomiasis Product Application Include:

S. haematobium

S. mansoni

S. japonicum

S. mekongi

S. intercalatum

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Drugs for Schistosomiasis Industry PESTEL Analysis

Chapter 3: Global Drugs for Schistosomiasis Industry Porter’s Five Forces Analysis

Chapter 4: Global Drugs for Schistosomiasis Major Regional Market Size and Forecast Analysis

Chapter 5: Global Drugs for Schistosomiasis Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Drugs for Schistosomiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Drugs for Schistosomiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Drugs for Schistosomiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Drugs for Schistosomiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Drugs for Schistosomiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Drugs for Schistosomiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Drugs for Schistosomiasis Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

170 Pages
1 Drugs for Schistosomiasis Market Overview
1.1 Product Definition and Statistical Scope
1.2 Drugs for Schistosomiasis Product by Type
1.2.1 Praziquantel
1.2.2 Oxamniquine
1.2.3 Others
1.3 Drugs for Schistosomiasis Product by Application
1.3.1 S. haematobium
1.3.2 S. mansoni
1.3.3 S. japonicum
1.3.4 S. mekongi
1.3.5 S. intercalatum
1.4 Global Drugs for Schistosomiasis Market Size Analysis (2020-2032)
1.5 Drugs for Schistosomiasis Market Development Status and Trends
1.5.1 Drugs for Schistosomiasis Industry Development Status Analysis
1.5.2 Drugs for Schistosomiasis Industry Development Trends Analysis
2 Drugs for Schistosomiasis Market PESTEL Analysis
2.1 Political Factors Analysis
2.2 Economic Factors Analysis
2.3 Social Factors Analysis
2.4 Technological Factors Analysis
2.5 Environmental Factors Analysis
2.6 Legal Factors Analysis
3 Drugs for Schistosomiasis Market Porter's Five Forces Analysis
3.1 Competitive Rivalry
3.2 Threat of New Entrants
3.3 Bargaining Power of Suppliers
3.4 Bargaining Power of Buyers
3.5 Threat of Substitutes
4 Global Drugs for Schistosomiasis Market Analysis by Regions
4.1 Drugs for Schistosomiasis Overall Market: 2024 VS 2025 VS 2032
4.2 Global Drugs for Schistosomiasis Revenue and Forecast Analysis (2020-2032)
4.2.1 Global Drugs for Schistosomiasis Revenue and Market Share by Region (2020-2025)
4.2.2 Global Drugs for Schistosomiasis Revenue Forecast by Region (2026-2032)
5 Global Drugs for Schistosomiasis Market Size by Type and Application
5.1 Global Drugs for Schistosomiasis Market Size by Type (2020-2032)
5.2 Global Drugs for Schistosomiasis Market Size by Application (2020-2032)
6 North America
6.1 North America Drugs for Schistosomiasis Market Size and Growth Rate Analysis (2020-2032)
6.2 North America Key Manufacturers Analysis
6.3 North America Drugs for Schistosomiasis Market Size by Type
6.4 North America Drugs for Schistosomiasis Market Size by Application
6.5 North America Drugs for Schistosomiasis Market Size by Country
6.5.1 US
6.5.2 Canada
7 Europe
7.1 Europe Drugs for Schistosomiasis Market Size and Growth Rate Analysis (2020-2032)
7.2 Europe Key Manufacturers Analysis
7.3 Europe Drugs for Schistosomiasis Market Size by Type
7.4 Europe Drugs for Schistosomiasis Market Size by Application
7.5 Europe Drugs for Schistosomiasis Market Size by Country
7.5.1 Germany
7.5.2 France
7.5.3 United Kingdom
7.5.4 Italy
7.5.5 Spain
7.5.6 Benelux
8 China
8.1 China Drugs for Schistosomiasis Market Size and Growth Rate Analysis (2020-2032)
8.2 China Key Manufacturers Analysis
8.3 China Drugs for Schistosomiasis Market Size by Type
8.4 China Drugs for Schistosomiasis Market Size by Application
9 APAC (excl. China)
9.1 APAC (excl. China) Drugs for Schistosomiasis Market Size and Growth Rate Analysis (2020-2032)
9.2 APAC (excl. China) Key Manufacturers Analysis
9.3 APAC (excl. China) Drugs for Schistosomiasis Market Size by Type
9.4 APAC (excl. China) Drugs for Schistosomiasis Market Size by Application
9.5 APAC (excl. China) Drugs for Schistosomiasis Market Size by Country
9.5.1 Japan
9.5.2 South Korea
9.5.3 India
9.5.4 Australia
9.5.5 Southeast Asia
10 Latin America
10.1 Latin America Drugs for Schistosomiasis Market Size and Growth Rate Analysis (2020-2032)
10.2 Latin America Key Manufacturers Analysis
10.3 Latin America Drugs for Schistosomiasis Market Size by Type
10.4 Latin America Drugs for Schistosomiasis Market Size by Application
10.5 Latin America Drugs for Schistosomiasis Market Size by Country
10.5.1 Mexico
10.5.2 Brazil
11 Middle East & Africa
11.1 Middle East & Africa Drugs for Schistosomiasis Market Size and Growth Rate Analysis (2020-2032)
11.2 Middle East & Africa Key Manufacturers Analysis
11.3 Middle East & Africa Drugs for Schistosomiasis Market Size by Type
11.4 Middle East & Africa Drugs for Schistosomiasis Market Size by Application
11.5 Middle East & Africa Drugs for Schistosomiasis Market Size by Country
11.5.1 Saudi Arabia
11.5.2 South Africa
12 Competition by Manufacturers
12.1 Global Drugs for Schistosomiasis Market Revenue by Key Manufacturers (2021-2025)
12.2 Drugs for Schistosomiasis Competitive Landscape Analysis and Market Dynamic
12.2.1 Drugs for Schistosomiasis Competitive Landscape Analysis
12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
12.2.3 Market Dynamic
13 Key Companies Analysis
13.1 Shin Poong
13.1.1 Shin Poong Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.1.2 Shin Poong Drugs for Schistosomiasis Product Portfolio
13.1.3 Shin Poong Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.2 Merck
13.2.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.2.2 Merck Drugs for Schistosomiasis Product Portfolio
13.2.3 Merck Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.3 Bayer
13.3.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.3.2 Bayer Drugs for Schistosomiasis Product Portfolio
13.3.3 Bayer Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.4 EIPICO
13.4.1 EIPICO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.4.2 EIPICO Drugs for Schistosomiasis Product Portfolio
13.4.3 EIPICO Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.5 Chandra Bhagat Pharma
13.5.1 Chandra Bhagat Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.5.2 Chandra Bhagat Pharma Drugs for Schistosomiasis Product Portfolio
13.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
13.6 Taj Pharmaceuticals
13.6.1 Taj Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
13.6.2 Taj Pharmaceuticals Drugs for Schistosomiasis Product Portfolio
13.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
14 Industry Chain Analysis
14.1 Drugs for Schistosomiasis Industry Chain Analysis
14.2 Drugs for Schistosomiasis Industry Raw Material and Suppliers Analysis
14.2.1 Drugs for Schistosomiasis Key Raw Material Supply Analysis
14.2.2 Raw Material Suppliers and Contact Information
14.3 Drugs for Schistosomiasis Typical Downstream Customers
14.4 Drugs for Schistosomiasis Sales Channel Analysis
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology/Research Approach
16.2 Research Scope
16.3 Benchmarks and Assumptions
16.4 Date Source
16.4.1 Primary Sources
16.4.2 Secondary Sources
16.5 Data Cross Validation
16.6 Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us